Literature DB >> 3009058

CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases.

J F Bergmann, M Beaugrand, H Labadie, J M Bidart, C Bohuon.   

Abstract

The presence of Ca 125, an ovarian cancer-associated antigen, was assessed in serum from patients with liver diseases with (n = 26) and without (n = 26) ascites. Abnormal levels of serum CA 125 were observed in all patients with ascites and in 4 patients without ascites (15%). We conclude that CA 125 is a non-specific marker of ascites whatever the origin: ovarian carcinoma, cirrhosis or peritoneal inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009058     DOI: 10.1016/0009-8981(86)90278-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Recent developments in the first detection of hepatocellular carcinoma.

Authors:  Joseph B Lopez
Journal:  Clin Biochem Rev       Date:  2005-08

2.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

3.  LETTER TO THE EDITOR: Is the Determination of CA-125 Serum Levels Useful for the Diagnosis of Pulmonary Tuberculosis?

Authors:  Julio Collazos
Journal:  Open Respir Med J       Date:  2010-03-19

Review 4.  HE4 as a biomarker for ovarian and endometrial cancer management.

Authors:  Jinping Li; Sean Dowdy; Tracy Tipton; Karl Podratz; Wei-Guo Lu; Xing Xie; Shi-Wen Jiang
Journal:  Expert Rev Mol Diagn       Date:  2009-09       Impact factor: 5.225

5.  CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension: A Retrospective Study.

Authors:  Raja Gr Edula; Sujit Muthukuru; Serban Moroianu; Yucai Wang; Vivek Lingiah; Phoenix Fung; Nikolaos T Pyrsopoulos
Journal:  J Clin Transl Hepatol       Date:  2018-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.